chelsea sawyer

Dr. chelsea sawyer

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
CSchelsea sawyer
chelsea sawyer
GMGrace McKeon
Grace McKeon
LHLamiece Hassan
Lamiece Hassan
HOHenry Onyweaka
Henry Onyweaka
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
JFJoseph Firth
Joseph Firth
The use of digital technologies as a method of delivering health behaviour change (HBC) interventions is rapidly increasing across the general population. However, the role in severe mental illness (SMI) remains overlooked. In this study, we aimed to systematically identify and evaluate all of the existing evidence around digital HBC interventions in people with an SMI. A systematic search of online electronic databases was conducted. Data on adherence, feasibility, and outcomes of studies on digital HBC interventions in SMI were extracted. Our combined search identified 2196 titles and abstracts, of which 1934 remained after removing duplicates. Full-text screening was performed for 107 articles, leaving 36 studies to be included. From these, 14 focused on physical activity and/or cardio-metabolic health, 19 focused on smoking cessation, and three concerned other health behaviours. The outcomes measured varied considerably across studies. Although over 90% of studies measuring behavioural changes reported positive changes in behaviour/attitudes, there were too few studies collecting data on mental health to determine effects on psychiatric outcomes. Digital HBC interventions are acceptable to people with an SMI, and could present a promising option for addressing behavioural health in these populations. Feedback indicated that additional human support may be useful for promoting adherence/engagement, and the content of such interventions may benefit from more tailoring to specific needs. While the literature does not yet allow for conclusions regarding efficacy for mental health, the available evidence to date does support their potential to change behaviour across various domains.

7 January 2025 in JMIR Mental Health
Verified
Journal Article
Open access
LHLamiece Hassan
Lamiece Hassan
AMAlyssa Milton
Alyssa Milton
CSchelsea sawyer
chelsea sawyer
ACAlexander Casson
Alexander Casson
JTJohn Torous
John Torous
JFJoseph Firth
Joseph Firth
Background: Digital wearable devices, worn on or close to the body, have potential for passively detecting mental and physical health symptoms among people with severe mental illness (SMI); however, the roles of consumer-grade devices are not well understood. Objective: This study aims to examine the utility of data from consumer-grade, digital, wearable devices (including smartphones or wrist-worn devices) for remotely monitoring or predicting changes in mental or physical health among adults with schizophrenia or bipolar disorder. Studies were included that passively collected physiological data (including sleep duration, heart rate, sleep and wake patterns, or physical activity) for at least 3 days. Research-grade actigraphy methods and physically obtrusive devices were excluded. Methods: We conducted a systematic review of the following databases: Cochrane Central Register of Controlled Trials, Technology Assessment, AMED (Allied and Complementary Medicine), APA PsycINFO, Embase, MEDLINE(R), and IEEE XPlore. Searches were completed in May 2024. Results were synthesized narratively due to study heterogeneity and divided into the following phenotypes: physical activity, sleep and circadian rhythm, and heart rate. Results: Overall, 23 studies were included that reported data from 12 distinct studies, mostly using smartphones and centered on relapse prevention. Only 1 study explicitly aimed to address physical health outcomes among people with SMI. In total, data were included from over 500 participants with SMI, predominantly from high-income countries. Most commonly, papers presented physical activity data (n=18), followed by sleep and circadian rhythm data (n=14) and heart rate data (n=6). The use of smartwatches to support data collection were reported by 8 papers; the rest used only smartphones. There was some evidence that lower levels of activity, higher heart rates, and later and irregular sleep onset times were associated with psychiatric diagnoses or poorer symptoms. However, heterogeneity in devices, measures, sampling and statistical approaches complicated interpretation. Conclusions: Consumer-grade wearables show the ability to passively detect digital markers indicative of psychiatric symptoms or mental health status among people with SMI, but few are currently using these to address physical health inequalities. The digital phenotyping field in psychiatry would benefit from moving toward agreed standards regarding data descriptions and outcome measures and ensuring that valuable temporal data provided by wearables are fully exploited. Trial Registration: PROSPERO CRD42022382267; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382267

24 January 2020 in Ear & Hearing
Verified
Journal Article
Open access
CSchelsea sawyer
chelsea sawyer
CAChristopher J. Armitage
Christopher J. Armitage
KMKevin J. Munro
Kevin J. Munro
GSGurjit Singh
Gurjit Singh
PDPiers D. Dawes
Piers D. Dawes
Objectives: Approximately 10 to 35% of people with a hearing impairment own a hearing aid. The present study aims to identify barriers to obtaining a hearing aid and inform future interventions by examining the biopsychosocial characteristics of adults aged 50+ according to 7 categories: (i) Did not report hearing difficulties, (ii) Reported hearing difficulties, (iii) Told a healthcare professional about experiencing hearing difficulties, (iv) Referred for a hearing assessment, (v) Offered a hearing aid, (vi) Accepted a hearing aid, and (vii) Reported using a hearing aid regularly. Design: The research was conducted using the English Longitudinal Study of Aging wave 7 with data obtained from 9666 adults living in England from June 2014 to May 2015. Cross-sectional data were obtained from a subset of 2845 participants aged 50 to 89 years of age with a probable hearing impairment measured by hearing screening (indicating a hearing threshold of >20 dB HL at 1 kHz or >35 dB HL at 3 kHz in the better ear). Classification according to hearing health-seeking category was via participants’ self-report. Participants in each category were compared with people in all subsequent categories to examine the associations between each category and biopsychosocial correlates (sex, age, ethnicity, educational level, wealth, audiometric hearing level, self-reported health status, cognitive performance, attitudes to aging, living alone, and engagement in social activities) using multiple logistic regression. Results: The proportions of individuals (N = 2845) in categories i to vii were 40.0% (n = 1139), 14.0% (n = 396), 4.5% (n = 129), 4.0% (n = 114), 1.2% (n = 34), 7.7% (n = 220), and 28.6% (n = 813), respectively. Severity of hearing impairment was the only factor predictive of all the categories of hearing health-seeking that could be modeled. Other correlates predictive of at least one category of hearing health-seeking included sex, age, self-reported heath, participation in social activities, and cognitive function. Conclusions: For the first time, it was shown that 40.0% of people with an audiometrically identified probable hearing impairment did not report hearing difficulties. Each of the five categories of hearing health-seeking that could be modeled had different drivers and consequently, interventions likely should vary depending on the category of hearing health-seeking.

1 August 2022 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
CSchelsea sawyer
chelsea sawyer
LHLamiece Hassan
Lamiece Hassan
DGDaniel Guinart
Daniel Guinart
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
JFJoseph Firth
Joseph Firth
Background: The large health disparities among those diagnosed with schizophrenia urgently need to be addressed. These disparities are partially caused by adverse health behaviours such as smoking. Smoking cessation apps vary in efficacy across various populations, and there are concerns regarding the accessibility and usability of apps for people with schizophrenia. Objective: This review identifies and examines the feasibility of using apps for smoking cessation in people with schizophrenia. Methods: A non-systematic narrative literature review of smoking cessation apps for individuals with schizophrenia was performed. Results: Eight studies were included in this review. Conclusion: Smoking cessation apps can be acceptable and feasible, but may need to be tailored to the needs of people with schizophrenia. Key messages: (1) Smoking cessation apps could be acceptable and feasible for use in people with schizophrenia; (2) Lack of motivation was perceived as the main potential barrier with regard to people with schizophrenia engaging with smoking cessation apps; (3) In order to improve motivation of people diagnosed with schizophrenia, apps could include games, rewards, and/or social support; (4) Smoking cessation apps with a simple interface seem to be beneficial for this population; (5) Apps may need to be tailored to consider this population’s mental health needs.

5 October 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
CSchelsea sawyer
chelsea sawyer
LPLaurie Preston
Laurie Preston
STSally Taylor
Sally Taylor
MDMichelle Davies
Michelle Davies
LCLouise Carter
Louise Carter
JYJanelle Yorke
Janelle Yorke
Objectives The study aimed to explore patients’ experiences of experimental cancer medicine (ECM) clinical trials. Design The study’s design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients’ experiences of ECM clinical trials. Interviews and focus groups were audiorecorded and transcribed verbatim. Data were analysed using thematic analysis. Setting A regional cancer centre (tertiary care) in North-West England. Participants Twelve patients (aged 52–79) participated in one of the two focus groups and 22 patients (aged 42–83) participated in interviews. Primary outcome measure Patients’ experiences of an ECM trial. Results Four main themes were identified from the analysis: decision making, information needs, the experience of trial participation and impact of trial participation. Subthemes are presented in the manuscript. Conclusion To make fully informed decisions about trial participation, patients required the simplification of trial information and wanted more information about side effects, their response to trial treatment and the overall trial progress throughout the trial. Patients highlighted the need for improvement for the support provided to their family and friends.

14 September 2024 in Psychiatry Research
Verified
Journal Article
Open access
JFJoseph Firth
Joseph Firth
CSchelsea sawyer
chelsea sawyer
JSJohn Sainsbury
John Sainsbury
RMRachel Morell
Rachel Morell
HFHamish Fibbins
Hamish Fibbins
KLKarina Lovell
Karina Lovell
Digital technologies have presented a myriad of new solutions for improving cardiometabolic and behavioural health in the general population. However, the ways in which such advances could be applied to address the heightened health-risk behaviours and associated diseases in mental healthcare is unknown. To examine this, 492 young people with mental illness (YPMI) were recruited from 27 Primary Care and NHS mental healthcare sites across the UK, covering various diagnoses (excluding eating disorders). Participants were presented with four types of physical health apps, delivering: 1) Health Tracking; 2) Health Coaching; 3) Health Connections; and 4) Instructional Videos, and completed an online perspective-gathering exercise on the preferred utility, features, behavioural targets of these technologies, and barriers/facilitators to uptake. Results showed a high level of perceived utility across each of the four app types, with physical activity, sleep and diet emerging as preferred behavioural targets. Feedback on ideal app features indicated a need for integrated physical-mental health tracking, and expert-led instructional content/coaching, with less interest expressed towards sharing data with clinical teams. These findings can improve the development, future trials, and clinical implementation of digital lifestyle interventions in mental healthcare, through better accounting for the needs and preferences of YPMI.